Aegerion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

AEGR 34.61 +2.33 (7.22%)
price chart
Aegerion Pharmaceuticals Given "Neutral" Rating at Zacks (AEGR)
Aegerion Pharmaceuticals, Inc. logo Aegerion Pharmaceuticals (NASDAQ:AEGR)'s stock had its �neutral� rating restated by Zacks in a research report issued on Friday.
Barbarian At The Gate: Aegerion Pharmaceuticals (AEGR)  TheStreet.com
Stocks in News: Navios Maritime Partners L.P. (NYSE:NMM), GoPro, Inc ...  Markets Insider
Related articles »  
Aegerion Pharmaceuticals (AEGR) Highlighted As Today's Perilous Reversal ...
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.
Aegerion Pharmaceuticals Receives Consensus Recommendation of "Hold ...  WKRB News
Related articles »  
Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma ...
Investor-Edge has initiated coverage on the following equities: Hemispherx Biopharma Inc. (nyse mkt:HEB), Aegerion Pharmaceuticals Inc. AEGR, +7.22% Cytori Therapeutics Inc. CYTX, +9.57% Alnylam Pharmaceuticals Inc. ALNY, -0.25% and Rexahn ...
Related articles »  
News Recap: Marchex, Inc. (MCHX), Aegerion Pharmaceuticals, Inc. (AEGR ...
Marchex, Inc. (NASDAQ:MCHX) operates as a mobile and call advertising technology company in the United States and Canada.
Related articles »  
AEGERION (AEGR) SHAREHOLDER ALERT - Andrews & Springer LLC Is ...
... law firm focused on representing shareholders nationwide, is investigating potential securities fraud claims and breach of fiduciary duty claims against the Board of Directors of Aegerion Pharmaceuticals, Inc. AEGR, -0.52% (�Aegerion� or the ...
Aegerion Pharmaceuticals Announces Presentation at the Leerink Rare Disease ...
Aegerion Pharmaceuticals, Inc. AEGR, -0.52% a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the ...
Related articles »  
Aegerion Pharmaceuticals Earns "Neutral" Rating from Zacks (AEGR)
Aegerion Pharmaceuticals, Inc. logo Zacks reissued their neutral rating on shares of Aegerion Pharmaceuticals (NASDAQ:AEGR) in a research report sent to investors on Friday morning.
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Aegerion Pharmaceuticals, Inc. AEGR, +4.69% a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on September 2, 2014, Aegerion ...
Related articles »  
Today's Perilous Reversal Stock: Aegerion Pharmaceuticals (AEGR)
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC identified Aegerion Pharmaceuticals ...
Aegerion Pharmaceuticals Announces Resolution of Warning Letter for ...  GlobeNewswire (press release)
Related articles »  
Today's Watch List: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR ...
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) has earned a consensus rating of �Hold� from the eleven ratings firms that are covering the stock.